Search for: "Ortho-McNeil Pharmaceutical"
Results 201 - 220
of 270
Sort by Relevance
|
Sort by Date
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
8 Jul 2009, 4:52 am
The FDA ordered Ortho-McNeil to include on Levaquin's label a warning about the incidence of those injuries. [read post]
1 Jul 2009, 7:00 am
Ortho-McNeil-Janssen Pharmaceuticals (part of Johnson & Johnson) now warns on their website: IMPORTANT SAFETY INFORMATION FOR LEVAQUIN Fluoroquinolones, including LEVAQUINââ [read post]
1 Jul 2009, 1:06 am
Levaquin, made by J&J subsidiary Ortho-McNeil Pharmaceutical Inc., was approved by the Food and Drug Administration in 1996, but in July 2008, the FDA warned that Levaquin, and other drugs in the fluoroquinolone class of antibiotics, put users at heightened risk of developing tendonitis and tendon ruptures. [read post]
29 Jun 2009, 7:01 am
Ohio citizen DeGidio sued non-resident drug companies -- Centocor, Johnson & Johnson, and Ortho-McNeil Pharmaceutical -- on product liability claims and, in the same complaint, sued Ohio resident health care providers -- Dr. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent Docs)… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
10 Jun 2009, 10:00 pm
Ortho-McNeil Pharmaceutical, 2007 WL 121149, at *4 (S.D. [read post]
10 Jun 2009, 9:02 pm
Seeking approval to market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. [read post]
29 May 2009, 7:33 am
“Three new Levaquin Lawsuits have been filed against Johnson & Johnson and Ortho-McNeil-Janssen Pharmaceuticals in New Jersey state court, joining other similar cases filed in state and federal courts throughout the country, alleging that the antibiotic caused plaintiffs to suffer painful tendon ruptures. [read post]
26 May 2009, 2:13 pm
From a May 13, 2009 Law.com article, "Levaquin Tendon Injury Mass Tort Treatment Sought for Suits Over Ortho-McNeil Antibiotic Levaquin": Users of Levaquin, an antibiotic linked to muscle ailments, are asking the New Jersey Supreme Court to accord mass-tort treatment to their suits against the manufacturer, Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical Inc. [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
13 May 2009, 1:31 am
Mass-Tort Treatment Sought for Suits Over Ortho-McNeil Antibiotic Levaquin
New Jersey Law Journal
Users of Levaquin, an antibiotic linked to muscle ailments, are asking the New Jersey Supreme Court to accord mass-tort treatment to their suits against the manufacturer, Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical. [read post]
21 Apr 2009, 8:45 am
Ortho-McNeil, Inc., No. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
20 Mar 2009, 2:05 am
., 416 F.2d 417, 426 (2d Cir. 1969).District of Columbia: McNeil Pharmaceutical v. [read post]
4 Feb 2009, 4:09 pm
Product liability cases against large conglomerates like Ortho-McNeil-Janssen Pharmaceuticals, Inc., can often be more than most attorneys can handle. [read post]
14 Nov 2008, 2:30 pm
The following information about Levaquin appears online at Wikipedia: “Levofloxacin is a third-generation fluoroquinolone antibiotic, marketed by Ortho-McNeil under the trade name Levaquin in the United States. [read post]
12 Nov 2008, 9:49 am
Ortho Diagnostics was looking for evidence of increased numbers of cancers (Ortho-McNeil is a subsidiary of Johnson & Johnson (J&J)). [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
